Internal Medicine, Hematology & Oncology · Farmington, CT
NPI
1003986852
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
6
Medicare group memberships
Hospitals
2
Hospital affiliations
11 South Rd
Farmington, CT, 06032
Phone (860) 679-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
374 services
Medicare patients, 2024
194
Average age 75
Drug cost, 2024
$732K
1,096 prescriptions
Company payments, 2025
$1,027
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel E Morganstern was code 99214 (office e&m - established), 209 times for 124 patients. In total Daniel E Morganstern billed 374 services in 12 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 209 | 124 | $69.05 | $14K |
| 99215 Office E&M - Established | Office | 50 | 24 | $103.18 | $5,159 |
| 99213 Office E&M - Established | Office | 41 | 39 | $49.01 | $2,009 |
| 99205 Office E&M - New | Office | 34 | 34 | $143.66 | $4,884 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $140.62 | $1,547 |
By year: 2022 $785K for 46,154 services; 2023 $36K for 416 services; 2024 $30K for 374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel E Morganstern prescribed most often to Medicare patients was Letrozole, with 317 prescriptions and refills. In total Daniel E Morganstern wrote 1,096 Medicare prescriptions that cost $732K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 317 | 905 | 105 | $8,508 |
| Tamoxifen Citrate Generic | 256 | 745 | 86 | $8,045 |
| Anastrozole Generic | 161 | 449 | 53 | $2,590 |
| Exemestane Generic | 33 | 82 | 11 | $3,030 |
| Verzenio Abemaciclib | 27 | 27 | Under 11 | $387K |
| Gabapentin Generic | 24 | 31 | Under 11 | $145 |
| Raloxifene Hcl Generic | 17 | 51 | Under 11 | $833 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $232 |
| Loperamide Loperamide Hcl | 15 | 15 | Under 11 | $142 |
| Alprazolam Generic | 14 | 14 | Under 11 | $88.04 |
| Estradiol Generic | 13 | 15 | Under 11 | $551 |
| Eliquis Apixaban | 12 | 12 | Under 11 | $6,799 |
| Dexamethasone Generic | 11 | 13 | Under 11 | $208 |
Brand drugs: 94 claims; generic drugs: 1,002 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel E Morganstern $1,027 ($1,027 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,000.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.